GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of MAP kinase activity | ||
adaptive immune response |
|
|
sphingosine-1-phosphate receptor signaling pathway | ||
G protein-coupled receptor signaling pathway | ||
cell migration |
GO Term | Evidence Code | PMID |
---|---|---|
kinase activity | ||
ephrin receptor binding | ||
1-phosphatidylinositol-3-kinase activity | ||
protein serine/threonine kinase activity | ||
protein serine kinase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:2007 | degeneration of macula and posterior pole | |
DOID:2018 | hyperinsulinism | |
DOID:2021 | placenta cancer | |
DOID:2043 | hepatitis B | |
DOID:205 | hyperostosis | |
DOID:2095 | sweat gland cancer | |
DOID:2129 | atypical teratoid rhabdoid tumor | |
DOID:2154 | nephroblastoma | |
DOID:219 | colon cancer | |
DOID:2224 | essential thrombocythemia |
HPO ID | HPO Term |
---|---|
HP:0002720 | Decreased circulating IgA level |
HP:0002850 | Decreased circulating total IgM |
HP:0002851 | Elevated proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells |
HP:0003281 | Increased circulating ferritin concentration |
HP:0003621 | Juvenile onset |
HP:0003651 | Foam cells |
HP:0004313 | Decreased circulating antibody level |
HP:0004315 | Decreased circulating IgG level |
HP:0004387 | Enterocolitis |
HP:0005415 | Decreased proportion of CD8-positive T cells |
Disease ID | Disease Name |
---|---|
OMIM:619802 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
114025261 | VOMUR06075 | ||
100950470 | OTOGA17825 | ||
101071229 | TAKRU18783 | ||
102028939 | CHILA02827 | ||
105720275 | AOTNA21031 | ||
110207004 | PHACI05645 | ||
101028650 | SAIBB02248 | ||
101955252 | ICTTR12167 | ||
102439715 | MYOLU02841 | ||
117012427 | RHIFE26840 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024